Wakefield Asset Management Lllp Amphastar Pharmaceuticals, Inc. Transaction History

Wakefield Asset Management Lllp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$44.49 - $62.93 $628,554 - $889,075	14,128 New	14,128 $873,000
Q4 2020 Feb 08, 2021	SELL	$17.76 - $21.24 $494,402 - $591,279	-27,838 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$17.99 - $22.22 $1,888 - $2,333	105 Added 0.38%	27,838 $522,000
Q2 2020 Jul 28, 2020	BUY	$14.25 - $22.46 $395,195 - $622,883	27,733 New	27,733 $623,000

279

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.58B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.